Objective. To establish the efficacy for treatments of pain on the plantar aspect of the heel. Methods. Systematic review of the published and unpublished literature. Electronic search of Medline, BIDS and the Cochrane database of clinical trials. An assessment of the quality of the reporting was made of studies included in the review. Main outcome measure: patients' pain scores. Study selection: randomized controlled trials, published or unpublished, that evaluated treatments used for plantar heel pain. Foreign language papers were excluded.
The painful heel is frequently seen in general practice, heel pads, orthoses, exercises, night splints and, in intractable cases, surgical procedures (Tables 1 and 2 ). rheumatology and podiatry clinics, in patients seeking a quick and effective cure. It has been estimated to affect However, much of the literature about treatment is based on authors' experiences and beliefs rather than 10% of runners and present in the general population at the same rate [1] . A variety of names are used to unbiased evaluations. This article reports what we believe to be the first systematic review of the efficacy describe heel pain: plantar fasciitis, jogger's heel, tennis heel, Policeman's heel [2] and gonorrhoeal heel [3] . The of commonly used treatments for the painful heel. last of these reflects the incorrectly presumed association between venereal disease and heel pain that prevailed in Methods the early 20th century. Although much has been written about this condition, little is known of the underlying Trials were included in the review if they were randomized or quasi-randomized (methods of allocating partidisease process or its natural evolution [4] . Since heel pain is recognized both as a feature of (predominantly cipants to treatments which are not strictly random, e.g. date of birth, hospital record number or alternation). seronegative) inflammatory rheumatic disease and as an isolated symptom in the normal population, it is likely Case studies, retrospective studies, descriptive articles or studies with historic controls only were excluded from that it can have either an inflammatory or mechanical origin. The degree of disability it causes can vary. Some the review, but all were tabulated to assess the available literature. Foreign language papers were excluded. patients experience a dull ache, while others report pain so great that it imposes a sedentary lifestyle. Patients Medline, from 1966 to June 1998, was searched using a generic search strategy described by Dickersin et al. often seek treatment only after experiencing heel pain for several weeks and some authors believe that the
[5] combined with 10 condition-specific items [6 ] . Additional searching was undertaken using the BIDS duration of pain affects the prognosis [4] . The most commonly described therapies are corticosteroid injecdatabase, from hand searching ally, the blinding of health professionals and patients to NSAIDs 15 treatment allocation [8] . The objectivity (blinding) of Heel pads 11 outcome measurements and loss to follow-up were Ultrasound 9 also assessed ( Disagreements were resolved by discussion.
Heel cups 4
Where summary statistics were either not reported or Rest 4 incompletely reported, the authors were contacted for [10] [11] [12] [13] [14] [15] [16] [17] [18] . Direct contact with schools of podiatry resulted Footbaths 1 in the identification of two randomized controlled trials which were unpublished dissertations [19, 20] . Two 
Surgical interventions (general ) 12
The search of the BIDS database, our hand search reports were excluded from the review ( Table 3 ). The
Countersinking osteotomy 1 conservative and surgical treatments described in both the included and excluded reports appear listed in order of frequency ( Tables 1 and 2 of which heel pain was one.
Total 167
Details of the eleven trials included in the review grouped according to intervention items within the Consolidated Standards of Reporting
We found no information in these articles on the natural Trials (CONSORT ) statement was developed and used course of the disease and the diagnostic features of heel to evaluate the design, conduct, analysis and generalizpain varied enormously. Table 4 shows the methodoability of trials, and to assess their internal validity [7] .
logical scores and sources of bias in the trials, whilst Two reviewers (FC and DA) independently applied Table 5 gives details of the trials' participants and these criteria to each reported trial (which had been blinded to obscure the authors) and scored them out of outcomes. 
VAS
Steroid injections and pads instruction, patients used the device at home, administering treatment for 5 min three times daily over 21 days.
Steroid injections vs viscoheel pads (Black et al. [19]). Patients were randomized to receive either a viscoheel
Extracorporeal shock wave therapy (ESWT) vs placebo (Rompe et al. [18] ). ESWT was applied using an experiheel pad or a heel injection of triamcinolone (Lederspan) 20 mg with 2% lignocaine. The injection group were mental device, the Siemens Osteostar. The device made contact with feet in the treatment group only, feet in advised to advised to rest for 48 h after the procedure.
Steroid injection vs saline injection (Blockey [12]).
the placebo group had the device held at a 1 cm distance. In the treatment group, the energy density was Painful heels were either injected with 25 mg hydrocortisone acetate or saline injection. All patients were 0.06 mJ/mm2 three times in weekly intervals. Extracorporeal shock wave therapy 1000 impulses vs also given a sponge heel pad.
Steroid injections alone vs pads alone vs steroid injec-10 impulses (Rompe et al. [22])
. ESWT was applied using an experimental device, the Siemens Osteostar. tions and pads (Kriss [21] ). In this three-arm trial, patients received either an anti-pronatory insole Patients in group 1 received 1000 impulses three times at weekly intervals, patients in group 2 received 10 or a steroid injection of triamcinolone hexacetonide (Lederspan) 20 mg mixed with 2% lignocaine or both.
impulses in the same time period. This second study of ESWT by Rompe et al. involved the largest number of Physical therapies patients in any of the trials in this review. Low-intensity laser therapy (Basford et al. [10] ). Affected feet were irradiated either with a 30 mW Insoles and night splints PPT insoles vs PPT insoles with magnetic foil (Caselli continuous-wave 0.83 mm GaA1As IR diode laser or a disabled laser probe. Treatment consisted of three et al. [13] ). Patients in the treatment group wore PPT Rx (type of mass-produced insole) firm moulded insoles periods of 33 s 'sweeps' at both the origin of the plantar fascia and the medial border.
containing a Nikken magnetic foil placed in the heel. Control group patients wore the same insole without True ultrasound vs placebo ultrasound (Crawford and Snaith [14] ). Episodes of heel pain were allocated to the magnetic foil. All patients wore the insole for 4 weeks, with no co-interventions. either true ultrasound at a dosage of 0.5 W/cm2, pulsed 1:4, 3 Mz for 8 min, or placebo ultrasound when only Night splints (Powell et al. [17] ). In their allocated intervention month, each patient received a night splint the timer was set. All patients received eight treatments in 4 weeks.
made of polypropylene with the ankle placed in 5°of dorsiflexion. Foam was used distally on the splint to Ionophoresis with dexamethasone vs ionophoresis with saline (Gudeman et al. [16] ). Group 1 patients were give 30°dorsiflexion at the MTP joints. Summary statistics (mean pain scores with standard treated with placebo ionophoresis (buffered saline) while group 2 patients received ionophoresis with dexamethodeviations) were available for only five reports [14, 20, 21, 23] . The outcomes for all trial participants are sone. All patients also received six sessions of ice and stretching programmes over a 2-3 week period.
reported in Table 6 . Seven studies reported excluding individuals with seropositive and seronegative condiBioelectron MKII (Nolan [20] ). This experimental device produced a beam of electrons, delivered onto the tions, [12-14, 17-19, 22] , and a further three excluded patients taking either steroids or NSAIDs, or both [10, surface of the skin via a probe. The manufacturers claimed that this reduced tissue acidity and restored the 20, 21]. Evaluations of lasers [10] , ultrasound [14] , steroid inflamed area to normal pH. Patients were randomized to receive either a functioning or a disabled device. After injections vs heel pads [19] , steroid injections vs saline [19] Steroids vs pads Improved Improved No Blockey [12] Steroids vs saline Improved Improved No Caselli [13] Insoles vs insoles with magnetic foil Improved Improved No Crawford [14] Ultrasound vs placebo Improved Improved No Gudeman [16 ] Ionophoresis and saline vs ionophoresis and steroids Improved Improved Yes (at first outcome) Kriss [21] Steroids alone vs insoles alone Improved Improved Yes Steroids + insoles vs steroids alone Improved Improved Yes Steroids + insoles vs insoles alone Improved Improved Yes Nolan [20] Bioelectron MKII vs placebo Improved Improved No Powell [17] Night splintsa Period A Period A no Yes improved improvement Rompe [22] Extracorporeal shock wave therapy; 1000 or 10 impulses Improved Improved Yes Rompe [18] Extracorporeal shock wave therapy vs placebo Improved Improved Yes aCross-over study.
[12], Bioelectron MKII [18] , and insoles with and imposed by medical journals. There was no apparent relationship between the trials' methodological scores without magnetic foil [13] failed to detect differences between the treatment and placebo groups ( Table 6) . and the conclusions they reached. The lack of homogeneity of treatments compared in All six trials had small sample sizes ( Table 5 ) and this may have resulted in either beneficial or detrimental the trials prevented us from pooling data, which, given treatment effects being undetected.
the small number of patients in the trials, might have In the five trials that did find statistically significant produced evidence for the treatment of painful heels improvements in pain, the evaluation of ionophoresis ( Table 4 ). The paucity of summary statistics either puband dexamethosone compared with ionophoresis and lished in the reports or made available after direct saline [16 ] showed an improvement in the outcomes of contact with the authors made any alternative analysis the dexamethosone group at 1 month only. At outcomes difficult. It was not possible to produce robust evidence taken thereafter, no differences were detected.
of effectiveness for any of the treatments evaluated in In the trial by Kriss [21] , the results showed that the included randomized controlled trials. patients who received steroid injections alone had the These shortcomings mean that moderate degrees of greatest improvement in pain levels. The main threats benefit from the treatments may well have been missed to the internal validity of this trial was the patients', (as have any detrimental effects). In future, trials evaluathealth professionals' and evaluators' knowledge of the ing treatments for heel pain may need to be multicentred, treatment allocation (Table 4) .
and the reports of all trials (but especially small studies) In both trials of ESWT [18, 22] , the health profesneed to contain detailed summary statistics to enable sionals were aware of the treatment allocation. The pooling of data (meta analysis). authors suggest that the painful nature of ESWT therapy
The trials included in this review suggest that many meant it was unlikely that patients were unaware of the observed treatment effects can be explained either by treatment allocation in the larger study, and in the placebo effects or by the spontaneous resolution of smaller study the equipment did not make contact with symptoms. As the natural evolution of heel pain is not the feet of patients in the placebo group.
fully understood, we were interested that (with the Although the cross-over trial of night splints [17] exception of the cross-over study by Powell et al. [17] ) reported improvements in patients' heel pain during the all trials included in this review reported some improvetreatment phase, both patients and health professionals ment in patients' mean pain scores in both treated and were aware of the treatment allocation. It is not reported non-treated populations ( Table 6 ). Given the relatively whether the evaluator of outcomes was objective.
short treatment period in some trials and the long The small sample sizes and failure to conceal treatduration of some patients' pain ( Table 5) , it is possible ment allocations from some or all trial participants that the observed effects can be explained due to the means that there are substantial threats to the validity placebo effect patients can experience simply from of the conclusions produced by these trials.
participating in a trial.
Conclusion

